BRIEF-CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products

* CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.